Cresemba 200mg

Cresemba 200mg is a medicine authorised by Swissmedic under authorisation number 66173. The authorisation holder is Basilea Pharmaceutica International AG, Allschwil. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 20 October 2017 and the authorisation is valid without a time limit. ATC code J02AC05 places the medicine in the group Antimycotics for systemic use.

  • Dispensing category A
  • Authorisation number 66173
  • ATC J02AC05
  • Synthetic medicines
Authorisation data
Authorisation number66173
NameCresemba 200mg
Full nameCresemba 200mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderBasilea Pharmaceutica International AG, Allschwil
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeJ02AC05
First authorisation20 October 2017
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Cresemba 200mg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungA20 October 2017

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)J02AC0508.06.0.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Cresemba 200mg authorised in Switzerland?

Yes. Cresemba 200mg is authorised by Swissmedic under authorisation number 66173, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Cresemba 200mg have?

Cresemba 200mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Cresemba 200mg?

The authorisation holder is Basilea Pharmaceutica International AG, Allschwil. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com